Antiserum specific for influenza A2 neuraminidase was produced by immunization of rabbits with the purified enzyme which had been isolated by electrophoresis from the proteins of a detergent-disrupted AoA2 influenza virus recombinant ]. This recombinant contained hemagglutinin of the Ao subtype and A2 neuraminidase. Antiserum to the isolated A2 neuraminidase did not react in any of four serological tests with Ao or A2 subtype viruses that lacked the A2 enzyme. In contrast, the antiserum inhibited the neuraminidase activity only of wild-type and recombinant viruses containing the A2 enzyme, regardless of the nature of their hemagglutinin proteins. The antiserum caused hemagglutination-inhibition of some, but not all, viruses bearing the A2 enzyme, and it reduced the plaque size or plaque number of all viruses tested that contained A2 neuraminidase. In the chick embryo and in cell culture, low dilutions of antiserum reduced the yield of virus. True neutralization of virus in the chick embryo did not occur. We conclude that an antiserum specific for A2 neuraminidase influenced the yield and release of virus from influenza virus-infected cells.
Recombination of Ao/NWS and A2/RI/5+ influenza viruses produced a virus, X-7, with Ao hemagglutinin and A2 neuraminidase (4, 7) . When X-7 virus was backcrossed with A2/RI/5+, another hybrid was produced [X-7 (Fl)] that was identical with X-7 in antigenic constitution, but which reacted differently in plaque-inhibition tests (3, 4) . Virus X-7 (Fl) and A2 wild-type virus have twice the amount of A2 enzyme as recombinant, X-7 (R. G. Webster, W. G. Laver, and E. D. Kilbourne, in press ). The derivation of X-7 and X-7 (Fl) viruses is diagrammed in Fig. 1 . It is clear that viral genetic recombination has effected a segregation of hemagglutinin and enzyme proteins. Furthermore, Laver and Kilbourne (7) have demonstrated that Ao/NWS (and hence X-7) hemagglutinin is denatured during disruption of these viruses with sodium dodecyl sulfate (SDS) so that subsequent electrophoresis of X-7 viral proteins results in a separation of A2 neuraminidase from residual contaminating hemagglutinin. This separation is not possible with the wild-type A2 parent in which both hemagglutinin and neuraminidase resist denaturation and have the same electrophoretic mobility. Thus, with X-7 and X-7 (Fl) viruses the separated enzyme can be eluted from the cellulose acetate strip as a presumably pure antigen uncontaminated with demonstrable biological or serological activity other than that associated with the neuraminidase (7). This paper describes the in vitro antiviral activity of influenza A2-specific neuraminidase antiserum prepared by immunization with the isolated enzyme of X-7 (Fl). A related paper discusses the effects in mice of active and passive immunization with the enzyme and its antiserum (J. S. Schulman, M. Khakpour, and E. D. Kilbourne, to be published).
MATERIALS AND METHODS
Cells. Clone 1-5C4, derived from the WongKilbourne variant of the human aneuploid Chang conjunctival cell line, was used for plaque-reduction tests (11) .
Viruses. Most of the viruses employed have been described in earlier reports. These include A2/RI/5+, A2/RI/5-, Ao/NWS, and Al/CAM, and recombinants X-1L, X-7(F1), X-9, and CAMr-, (4, 12 Hemagglutination-inhibition tests. Hemagglutination-inhibition tests were performed by methods described previously (14) .
Neuraminidase assay and enzyme-inhibition tests. Enzyme assays and enzyme-inhibition tests were performed with a fetuin substrate as described previously (7) . Viruses employed in enzyme assays were grown in the allantoic sac of 10-to 11 -day-old chick embryos and were stored as allantoic fluid suspensions at -95 C. In most instances, diluted allantoic fluid suspensions of freshly thawed intact viruses were used as enzyme, and they were adjusted so that sufficient N-acetyl neuraminic acid was liberated to give optical density (OD) readings of 0.300 to 0.900 at 549 m,u in a Bausch & Lomb Spectronic-20 colorimeter or in a 1.0-cm cell in a Beckman DU-2 spectrophotometer. Titers of antisera are expressed as that dilution which causes 50% inhibition of the neuraminidase activity of X-7 (Fl) virus adjusted to give OD readings in the presence of dilutions of normal rabbit serum of 0.300 to 0.380.
Isolation of A2 neuraminidase used in immunization. Virus X-7(F1), purified by adsorption-elution on red cells, differential centrifugation, and sedimentation through a sucrose gradient (7) , was disrupted with SDS, and the protein components were separated by electrophoresis. on cellulose acetate as described previously (6) .
The protein band with A2-type neuraminidase activity was eluted from the cellulose acetate strips with 0.15 M NaCl (7) . (The enzyme from 12 strips was eluted with 7.0 ml.) The enzyme solution was placed in an ice bath overnight, and SDS which precipitated was removed by centrifugation. The enzyme in the supernatant fluid was freed further from SDS and buffer salts, and, at the same time, was concentrated by cold acetone precipitation. The solution of enzyme (7.0 ml) was cooled to 0 C, and cold (-20 C) acetone (25 ml) was added slowly with constant stirring. The mixture was allowed to stand overnight in an ice bath and then was centrifuged at 0 C (2,500 rev/min for 15 min). The supernatant liquid was poured off and discarded, and the tube drained for a few minutes at 0 C. The enzyme precipitate was then dissolved in cold 0.15 M NaCl (1.0 ml). Incubation of 1 ,liter of this preparation with fetuin for 30 min in the standard enzyme assay gave an OD reading of 0.365. RESULTS Immunization procedure. Six male rabbits (1.3 to 1.8 kg) were injected in the footpad with 0.3 ml of a mixture of equal parts of aqueous dilutions of isolated neuraminidase and complete Freund's adjuvant. Antigen dilutions of 1:17, 1: 67, and 1:267 induced neuraminidase antibody titers of 1:5,000 or more, 72 days after injection, but antigen diluted 1:1,069 or 1:4,275 did not induce neuraminidase-inhibiting antibody. In one rabbit (R-296) injected with the lowest dilution (1 :10) of enzyme, serum specimens were obtained for study immediately prior to injection of antigen, 13, 22, 40, 47, 106, and 159 days afterward. A booster injection identical to the initial one was given on the 40th day. As presented in Table 1 , antibody to the A2 neuraminidase of X-7 (Fl) virus appeared promptly in high titer, but hemagglutination-inhibiting antibody for X-7 and X-7 (F1) (hemagglutinin = Ao) appeared only in very low titer (1:20 dilution) after the booster injection. Plaque size-reducing (PSR) activity was demonstrable with high dilutions of serum (titer > 1 :1,000,000 with the 47-day specimen). PSR has been correlated with inhibition of the viral enzyme (3). Not unexpectedly, the curves of direct enzyme inhibition and PSR were not parallel, as the former effect involved direct inactivation of enzyme in vitro, but PSR was an indirect measure of inhibition of viral replication (3). The enzyme-inhibition titration of the 47-day serum is shown in Fig. 2 .
Evidence for the A2 specificity ofviral neuraminidase inhibition by the R-296 antiserum produced to the neuraminidase fraction of X-7 (Fl) virus. Serum obtained 22 days after immunization with the neuraminidase fraction of X-7 (Fl) virus was tested at a 1 :100 initial dilution for its capacity to inhibit enzymatic (neuraminidase) activity of influenza A viruses of various subtypes. The homologous enzyme-inhibition titer of this serum was 1:3,000. The data from an experiment comparing the 0-and 22-day sera are given in Table 2 . Significant inhibition of viral neuraminidase activity was found only with the wild-type A2 strains RI/5+ and RI/5-or with recombinants derived from them [X-1L, X-7, X-7 (Fl), and X-15] in which inhibition of enzymatic activity with A2 antiserum had previously been demonstrated. In this table, and in subsequent ones, the A2 enzyme is represented as E, and the less stable enzymes ofthe AO and A1 subtypes are represented as e and e', respectively. Results obtained with the same viruses and the 47-day serum were the same as the data presented in Table 2 . We concluded that the antiserum is specific for the A2 neuramini- (Table 3) . Thus, the low-titer hemagglutination-inhibiting activity of the antiserum with X-7 and X-7 (Fl) viruses is readily explained as a consequence of reaction with their A2 enzyme components, and it does not seem to be effected by antibodies to a cryptic Ao or A2 hemagglutinin component contaminating the extracted neuraminidase used in immunization.
We noted that the R-296 47-day serum had appreciable hemagglutination-inhibiting activity with the inhibitor-sensitive, antibody-avid I (5) or "+" (1) A2E strains RI/5+ and X-1L (Table 3) . But the antiserum did not inhibit the inhibitor-and antibody-resistant (i, "-") RI/5-strain that is antigenically identical to RI/5+ (1). Thus, this reactivity may also be explained by the reaction at the enzyme site and does not necessarily suggest the presence in R-296 antiserum of influenza virus antibodies other than Table 4 . Agar overlays containing serial fourfold dilutions of R-296 antiserum (47-day bleeding) were then added, and these dishes were examined 4 days later after crystal violet staining for reduction in plaque number (plaque inhibition, PI) or plaque size PSR (3). As noted in Table 4 , extremely high dilutions of antiserum ( >1 :1,000,000) affected plaque formation by all viruses that contained A2 neuraminidase (E), but was not influenced at the lowest dilution used (1:500). The results with X-7, X-7 (Fl), and X-1L viruses were consistent with the patterns reported previously for these viruses when titrated against A2/RI/5+ antiserum, i.e., complete plaque inhibition of X-1L and of X-7 (Fl) which contained more neuraminidase (Webster et al., to be published) and PSR of X-7 (2). Virus X-12 was apparently identical antigenically with X-7, but it had derived its neuraminidase from RI/5-rather than from RI/5+.
Neutralization in chick embryos. Several viruses containing differing hemagglutinin moieties and either E (A2) or e (Ao) enzyme components were serially diluted in decimal series. To each virus dilution, a 1:10 dilution of either the 0-day or 22-day serum of R-296 was added, and the mixtures were maintained at 4 C for 1 hr before intra-allantoic inoculation of 10-day-old chick embryos. The allantoic fluids were harvested after the eggs were incubated for 40 hr and tested at dilutions of 1:4 with 0.5% suspensions of human group 0 RBC for hemagglutinin, as in a conventional neutralization titration. Titration end points were read on the basis of this result (Table  5) . We noted that titration end points of viruses containing the A2 enzyme (E) were reduced 1 to 3 logs by the 22-day antineuraminidase serum. However, when allantoic fluids from eggs negative for hemagglutinating virus were inoculated at a 1 :10 dilution into other eggs, in an attempt to demonstrate infective virus below the threshold of detectable hemagglutination, the significant difference in titration end points disappeared. That is, some eggs inoculated with high dilutions of virus and neuraminidase antiserum contained infective virus, although in the conventional test they had been read as "negative." Furthermore, hemagglutination titrations of positive allantoic fluids from X-7 (Fl) virus infection demonstrated lower yields of hemagglutinating virus in eggs infected in the presence of neuraminidase antiserum (Table 6 ). Thus, true neutralizationi.e., reduction in initial infective dose-was not effected with the neuraminidase antiserum in eggs, but rather a reduction in viral yields resulted after inoculation. This effect is analogous to PSR and to the results obtained with X-7 virus in chorioallantoic membrane fragments in vitro with antineuraminidase antibodies obtained by viral absorption from X-7 antiserum (13) .
Preinoculation neutralization of plaque formation. Mixtures of 100 to 150 PFU of virus (X-7, X-7 (Fl), X-1L, NWS, and X-9) and serial twofold dilutions of 22-day R-296 antiserum were added to clone 1-5C-4 cell monolayers. The 0-day serum of R-296 served as a control. After a 30-min absorption period, monolayers were washed once with 10 ml of 199, and agar overlays were added as usual. Plaques were measured and counted after crystal violet staining, following 4 days of incubation of the dishes. Titration end points with the various viruses were as follows: X-7, 1:24; X-7 (Fl), 1:192; X-1L, 1:384; NWS and X-9, < 1:8. This apparent neutralizing reactivity against E-containing viruses in the cell culture system was low level (i.e., <103), compared to the high activity of antiviral antisera in similar titrations (104 to 105); this suggested that the large number of antineuraminidase antibody a Each of a decimal series of virus dilutions was added to a 1:10 dilution of either R-296 22 day or normal serum, maintained for 60 min at 4 C and was then inoculated into chick embryos; allantoic fluids were harvested after 40 hr of inoculation at 35 C and were tested at 1:4 dilution for hemagglutinating virus. Titration end points were read on the basis of this result and again after subinoculation into chick embryos of fluids negative for hemagglutinin (2nd passage).
bAnti-E = neuraminidase antiserum (R-296, 22-day bleeding); NRS = normal rabbit serum. Effect of neuraminidase antiserum on yield and release of X-7 (AoE) virus from clone 1-SC-4 cells. Evidence was obtained from the following experiment that the essential effect of antineuraminidase antibody in cell cultures is on yield of virus from cells. Clone 1-5C-4 monolayers were inoculated with either 5.0 or 0.05 PFU per cell of X-7 virus. After the cells were washed, maintenance medium, containing 1% of R-296 22-day or 0-day serum, was added to the cultures (Table 7) , which were then incubated for 20 hr-a period optimal for maximal production of infective virus following high multiplicity of infection (11) . Culture fluids were removed and centrifuged at 8,000 x g for 5 min. Supernatant fluids were diluted in a 10-fold series and inoculated into eggs for determination of EID50 yields of infective virus. At the lowest dilution of culture fluid employed (10-1), it can be calculated that the final dilution of the original serum was at least 10-' in the chick-embryo allantoic sac (0.1 ml of 10-1 inoculated into 10 ml of allantoic fluid). Thus, the dilution was less than the amount required to produce reduction of virus yields in the chick embryo or to affect testing of allantoic fluid harvests for hemagglutinin. Reduction (10-to 50-fold) in the yield of fluid-phase infective virus was demonstrated in this experiment (Table 7) . (10) . In chick-chorioallantoic membrane cultures in liquid media, the continued presence of enzyme antibody is necessary for apparent neutralization of virus (13) . All these studies in different laboratories using different systems indicate that the primary role of viral neuraminidase is not in the initial steps of infection but rather in later events related to the release and spread of virus from infected cells.
The antigenic dissimilarity of the neuraminidase and hemagglutinin of influenza virus, suggested previously by Rafelson's studies (9) , has been clearly demonstrated by our experiments, which also support the earlier inference that the enzyme and hemagglutinin sites on the influenza virion are not identical (2, 8) .
